Administration of estraciol-17B to male Xenopus laevis induces liver cell differentiation and the synthesis of massive amounts of the egg yolk precursor protein, vitellogenin, apo very low density lipoprotein II (apo VLDLII), and several other proteins. We propose to examine the role of 5' flanking sequences in transcription using the relatively simple apo VLDLII gene system, rather than the large and structurally complex vitellogenin gene family. Our approach will be examine the transcription, after microinjection into Xenopus oocyte nuclei, of a series of cloned deletions in the 5' flanking regions of the DNA and to develop an assay for transcription regulatory factors, by coinjection into Xenopus oocyte nuclei, of intact nuclei from unstimulated cells and extracts from estrogen stimulated cells. cDNA clones of apo VLDLII will be selected by plus-minus hybridization. Genomic clones will be selected from our Xenopus library. Using solution hybridization and transcription rate measurements, the essential features of th estrogen induction of apo VLDLII mRNA will be characterized. The 5' flanking sequences in chromatin will be examined for sites hypersensitive to DNase I digestion. DNA methylation patterns of transcriptionally active and inactive apo VLDLII genes and their flanking regions will be determined. The 5' flanking sequences required for efficient and accurate transcription will be identified by construction of a series of 5' and 3' deletion mutants using the Bal 31 digestion method, and injecting these deletions into homologous Xenopus oocyte nuclei. Blot hybridization and moderate probe excess solution hybridization will be used to quantitate the accuracy and efficiency of transcription. An assay for cellular proteins which mediate estrogen regulated gene expression will be established by microinjecting 500-1,000 intact liver cell nuclei, from unstimulated or estrogen stimulated cells, into each Xenopus ooxyte nucleus. If the original liver cell transcription pattern is perserved in oocyte nuclei (this is the case for somatic 5S genes), extracts from estrogen stimulated nuclei and nuclei from unstimulated cells will be coinjected into oocytes in an effort to activate transcription of the apo VLDLII genes.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD016720-05
Application #
3313876
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1982-07-01
Project End
1987-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Illinois Urbana-Champaign
Department
Type
Schools of Arts and Sciences
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Zhou, Jian-Hua; Yu, David V; Cheng, Jingwei et al. (2007) Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death. Steroids 72:765-77
Cheng, Jingwei; Yu, David V; Zhou, Jian-Hua et al. (2007) Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis. J Biol Chem 282:30535-43
Cheng, Jingwei; Zhang, Chen; Shapiro, David J (2007) A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen. Endocrinology 148:4634-41
Jiang, X; Ellison, S J; Alarid, E T et al. (2007) Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 26:4106-14
Wang, Stanley; Zhang, Chen; Nordeen, Steven K et al. (2007) In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors alpha and beta supports an active displacement model for coregulator utilization. J Biol Chem 282:2765-75
Jiang, Xinguo; Orr, Brent A; Kranz, David M et al. (2006) Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells. Endocrinology 147:1419-26
Krieg, Adam J; Krieg, Sacha A; Ahn, Bonnie S et al. (2004) Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J Biol Chem 279:5025-34
Wang, Stanley Y; Ahn, Bonnie S; Harris, Rebecca et al. (2004) Fluorescence anisotropy microplate assay for analysis of steroid receptor-DNA interactions. Biotechniques 37:807-8, 810-7
Kannan-Thulasiraman, Padma; Shapiro, David J (2002) Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9. J Biol Chem 277:41230-9
Krieg, S A; Krieg, A J; Shapiro, D J (2001) A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1). Mol Endocrinol 15:1971-82

Showing the most recent 10 out of 47 publications